Literature DB >> 16040169

Oral immunization with a shiga toxin B subunit: rotavirus NSP4(90) fusion protein protects mice against gastroenteritis.

Nak-Won Choi1, Mary K Estes, William H R Langridge.   

Abstract

A fusion protein containing the shiga toxin-1 B subunit (STB) linked to a 90 amino acid peptide (aa residues 86--175) from simian rotavirus (SA--11) nonstructural protein NSP4 was synthesized in Escherichia coli. Mice orally inoculated with 60 microg of STB::NSP4(90) fusion protein per dose generated higher humoral and intestinal antibody titers than mice inoculated with 30 microg of NSP4 alone. Serum anti-NSP4 IgG2a isotype titers were substantially greater than IgG1 titers, suggesting a dominant Th1 immune response. ELISA measurement of cytokines secreted from splenocytes isolated from immunized mice confirmed the STB::NSP4(90) fusion protein stimulation of a strong Th1 cell mediated immune response. Diarrhea in SA-11 rotavirus challenged neonates suckling from STB::NSP4 immunized dams was significantly reduced in severity and duration in comparison with virus challenged neonates from unimmunized mice. Together, our experiments demonstrate for the first time that the shiga toxin B subunit provides ligand mediated delivery of virus antigens to the gut-associated lymphoid tissues for enhanced stimulation of humoral and cellular responses against rotavirus gastroenteritis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040169     DOI: 10.1016/j.vaccine.2005.06.015

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Epitope mapping and use of epitope-specific antisera to characterize the VP5* binding site in rotavirus SA11 NSP4.

Authors:  Joseph M Hyser; Carl Q-Y Zeng; Zanna Beharry; Timothy Palzkill; Mary K Estes
Journal:  Virology       Date:  2007-12-31       Impact factor: 3.616

2.  Human VP8* mAbs neutralize rotavirus selectively in human intestinal epithelial cells.

Authors:  Ningguo Feng; Liya Hu; Siyuan Ding; Mrinmoy Sanyal; Boyang Zhao; Banumathi Sankaran; Sasirekha Ramani; Monica McNeal; Linda L Yasukawa; Yanhua Song; B V Venkataram Prasad; Harry B Greenberg
Journal:  J Clin Invest       Date:  2019-08-12       Impact factor: 14.808

3.  Modification in media composition to obtain secretory production of STxB-based vaccines using Escherichia coli.

Authors:  Mohammad Sadraeian; Mohammad Bagher Ghoshoon; Milad Mohkam; Zeinab Karimi; Sara Rasoul-Amini; Younes Ghasemi
Journal:  Virol Sin       Date:  2013-01-17       Impact factor: 4.327

Review 4.  Rotaviruses: from pathogenesis to vaccination.

Authors:  Harry B Greenberg; Mary K Estes
Journal:  Gastroenterology       Date:  2009-05-07       Impact factor: 22.682

5.  Expression of a ricin toxin B subunit: insulin fusion protein in edible plant tissues.

Authors:  James E Carter; Oludare Odumosu; William H R Langridge
Journal:  Mol Biotechnol       Date:  2010-02       Impact factor: 2.695

6.  A recombinant hybrid peptide composed of AAF adhesin of enteroaggregative Escherichia coli and Shiga toxin B subunit elicits protective immune response in mice.

Authors:  M Oloomi; S Bouzari; S Emami
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-08-05       Impact factor: 3.267

Review 7.  Rotavirus vaccines and pathogenesis: 2008.

Authors:  Joseph M Hyser; Mary K Estes
Journal:  Curr Opin Gastroenterol       Date:  2009-01       Impact factor: 3.287

8.  Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine.

Authors:  Cunbao Liu; Pengwei Huang; Dandan Zhao; Ming Xia; Weiming Zhong; Xi Jiang; Ming Tan
Journal:  Vaccine       Date:  2020-12-11       Impact factor: 4.169

Review 9.  Viral gastroenteritis.

Authors:  Krisztián Bányai; Mary K Estes; Vito Martella; Umesh D Parashar
Journal:  Lancet       Date:  2018-06-29       Impact factor: 79.321

10.  Expression of Bordetella pertussis Antigens Fused to Different Vectors and Their Effectiveness as Vaccines.

Authors:  Han Xu; Jing Huang; Zhaolu Liu; Xin Li; Kangfeng Wang; Erling Feng; Jun Wu; Li Zhu; Kaihu Yao; Chao Pan; Hengliang Wang
Journal:  Vaccines (Basel)       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.